Literature DB >> 17607939

The ras signalling pathway as a target in cancer therapy.

Kathryn Graham1, Michael F Olson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607939     DOI: 10.1007/978-3-540-31209-3_8

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


× No keyword cloud information.
  5 in total

1.  Different effect of protein kinase B/Akt and extracellular signal-regulated kinase inhibition on trichostatin A-induced apoptosis in epithelial ovarian carcinoma cell lines.

Authors:  Eun-Ra Jang; Yun Jeong Kim; Soon Chul Myung; Wonyong Kim; Chung Soo Lee
Journal:  Mol Cell Biochem       Date:  2011-03-06       Impact factor: 3.396

2.  Combined effect of protein kinase B inhibitor or extracellular signal-regulated kinase inhibitor against farnesyltransferase inhibition-induced apoptosis in SiHa cells.

Authors:  Sun Joo Lee; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

3.  Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.

Authors:  Yan Huang; Guo-Ping Ren; Chao Xu; Shui-Feng Dong; Ying Wang; Yun Gan; Li Zhu; Tian-Yuan Feng
Journal:  BMC Cancer       Date:  2014-07-03       Impact factor: 4.430

4.  Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells.

Authors:  Xi-Feng Zhang; Qi Yan; Wei Shen; Sangiliyandi Gurunathan
Journal:  Int J Mol Sci       Date:  2016-08-19       Impact factor: 5.923

5.  Regulation of a Novel Splice Variant of Early Growth Response 4 (EGR4-S) by HER+ Signalling and HSF1 in Breast Cancer.

Authors:  Jeremy M Drake; Benjamin J Lang; Martin Eduardo Guerrero-Gimenez; Jack Bolton; Christopher A Dow; Stuart K Calderwood; John T Price; Chau H Nguyen
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.